Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10,485 | 51,800 | 14,384 | -6,956 | 3,991 |
| Depreciation Amortization | 10,166 | 38,200 | 28,155 | 17,770 | 8,840 |
| Income taxes - deferred | 4,299 | 5,200 | 4,814 | 547 | 2,964 |
| Accounts receivable | 10,561 | -22,400 | 45,035 | 53,933 | 51,207 |
| Accounts payable and accrued liabilities | 81 | -14,800 | -1,305 | 11,287 | 385 |
| Other Working Capital | 12,150 | -44,300 | 11,233 | 26,487 | 26,047 |
| Other Operating Activity | -6,071 | 40,900 | -35,065 | -62,893 | -51,263 |
| Operating Cash Flow | $41,671 | $54,600 | $67,251 | $40,175 | $42,171 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20,304 | -76,200 | -56,243 | -39,246 | -18,214 |
| Investing Cash Flow | $-20,304 | $-76,200 | $-56,243 | $-39,246 | $-18,214 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,957 | 17,100 | 14,981 | 14,524 | 3,595 |
| Common Stock Repurchased | -81 | N/A | N/A | 0 | 0 |
| Other Financing Activity | -25,583 | -36,900 | -39,991 | 4,979 | 657 |
| Financing Cash Flow | $-22,707 | $-19,800 | $-25,010 | $19,503 | $4,252 |
| Exchange Rate Effect | -3 | 100 | 139 | 168 | 11 |
| Beginning Cash Position | 271,513 | 312,800 | 312,795 | 312,795 | 312,795 |
| End Cash Position | 270,170 | 271,500 | 298,932 | 333,395 | 341,015 |
| Net Cash Flow | $-1,343 | $-41,300 | $-13,863 | $20,600 | $28,220 |
| Free Cash Flow | |||||
| Operating Cash Flow | 41,671 | 54,600 | 67,251 | 40,175 | 42,171 |
| Capital Expenditure | -20,304 | -76,200 | -56,243 | -39,246 | -18,214 |
| Free Cash Flow | 21,367 | -21,600 | 11,008 | 929 | 23,957 |